{
  "id": "4ddf1f77b6fe1ef0",
  "title": "STAT+: Supreme Court agrees to review \u2018skinny labeling\u2019 and generic drug access",
  "description": "The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely watched for its implications for the availability of generic medicines.",
  "content": "The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely watched for its implications for the availability of generic medicines.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/16/scotus-generics-patents-supreme-court-amarin-hikma/?utm_campaign=rss",
  "published_at": "2026-01-16T21:03:39+00:00",
  "fetched_at": "2026-01-17T00:22:29.333379+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "supreme court",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Supreme Court agrees to review \u2018skinny labeling\u2019 and generic drug access",
    "description": "The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely watched for its implications for the availability of generic medicines.",
    "url": "https://www.statnews.com/pharmalot/2026/01/16/scotus-generics-patents-supreme-court-amarin-hikma/?utm_campaign=rss",
    "published": "2026-01-16T21:03:39+00:00",
    "source": "STAT"
  }
}